Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Huang, Raymond Y; Unadkat, Prashin; Linda Bi, Wenya; George, Elizabeth; Preusser, Matthias; McCracken, D Jay; Keen, Joseph R; Read, William L; Olson, Jeffrey J; Seystahl, Katharina; Le Rhun, Emilie; Roelcke, Ulrich; Koeppen, Susanne; Furtner, Julia; Weller, Michael; Raizer, Jeffrey J; Schiff, David; Wen, Patrick Y (2018). Response Assessment of Meningioma: 1D, 2D and Volumetric Criteria for Treatment Response and Tumor Progression. Neuro-Oncology:Epub ahead of print.

Seystahl, Katharina; Papachristodoulou, Alexandros; Burghardt, Isabel; Schneider, Hannah; Hasenbach, Kathy; Janicot, Michel; Roth, Patrick; Weller, Michael (2017). Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma. Molecular Cancer Therapeutics, 16(6):1177-1186.

Seystahl, Katharina; Gramatzki, Dorothee; Roth, Patrick; Weller, Michael (2016). Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives. Expert Opinion on Pharmacotherapy, 17(9):1259-70.

Seystahl, Katharina; Stoecklein, Veit; Schüller, Ulrich; Rushing, Elisabeth; Nicolas, Guillaume; Schäfer, Niklaus; Ilhan, Harun; Pangalu, Athina; Weller, Michael; Tonn, Jörg-Christian; Sommerauer, Michael; Albert, Nathalie L (2016). Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake. Neuro-Oncology, 18(11):1538-1547.

Seystahl, Katharina; Wick, Wolfgang; Weller, Michael (2016). Therapeutic options in recurrent glioblastoma-An update. Critical Reviews in Oncology/Hematology, 99:389-408.

Tonder, Michaela; Eisele, Günter; Weiss, Tobias; Hofer, Silvia; Seystahl, Katharina; Valavanis, Antonios; Stupp, Roger; Weller, Michael; Roth, Patrick (2014). Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica, 53(10):1436-1440.

This list was generated on Wed Mar 20 06:46:34 2019 CET.